Target intelligence / Profile preview

RNA, U6 small nuclear 1073, pseudogene (RNU6-1073P)

Target: RNU6-1073P
Molecular classification: Other (pseudogene of a small nuclear RNA), Small nuclear RNA pseudogene

Overview

RNU6-1073P encodes a pseudogene derived from U6 small nuclear RNA, which is a core component of the U6 snRNP and centrally involved in the splicing of pre-mRNA in eukaryotic cells[4][5]. While functional U6 snRNA is essential for proper spliceosome assembly and pre-mRNA processing, the RNU6-1073P pseudogene is a non-functional, noncoding genetic element. Such pseudogenes can arise through retrotransposition events mediated by LINE-1 (L1) elements, but they do not generate functional RNA or protein. U6 snRNA pseudogenes are sometimes used as genetic markers to study genome dynamics and retrotransposition history but have no established biological, therapeutic, or diagnostic role[4][1][5]. Summary: - RNU6-1073P is a pseudogene, not a protein, receptor, or conventional drug target. - It does not encode a functional product or have a direct biological or pharmacological role. - There are no known interacting drugs, biomarkers, or therapeutic implications associated with this pseudogene[4][5].

Other names: RNU6-1073PU6 pseudogene 1073U6 snRNA pseudogene 1073RNA, U6 small nuclear 1073, pseudogene

Mechanism of action

none. No mechanism, as it is not targeted by therapeutics.

Biological functions

none (as a pseudogene). The parental gene (U6 snRNA) is involved in splicing, but the pseudogene has no biological activity[4][5].

Disease associations

none known. There is no evidence linking this specific pseudogene to disease processes or functional roles in pathology[4].

Safety considerations

none. Not used therapeutically or diagnostically; not expressed as a functional product.

Interacting drugs

none. There are no drugs known to interact with this pseudogene.

Biomarkers

none. There is no support for this pseudogene being a biomarker for any diagnostic or therapeutic purpose.

Beyond the preview

Go deeper on RNA, U6 small nuclear 1073, pseudogene (RNU6-1073P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1073, pseudogene (RNU6-1073P).

Explore the full profile